
Lantheus Holdings
Lantheus Medical Imaging, a global leader in developing, manufacturing, selling.
USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 25 % | 120 % | 39 % | 18 % | 3 % | 10 % | 12 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (20 %) | 4 % | 34 % | 36 % | 44 % | 45 % | 48 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (17 %) | 3 % | 25 % | 20 % | 16 % | 24 % | 26 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 11 % | 33 % | 6 % | 11 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Lantheus is a leading company specializing in innovative diagnostics, targeted therapeutics, and artificial intelligence (AI) solutions designed to empower clinicians in the healthcare sector. Operating primarily in the medical diagnostics and therapeutics market, Lantheus serves healthcare providers, including hospitals, clinics, and specialized medical practitioners. The company’s business model revolves around the development, manufacturing, and commercialization of pioneering diagnostic and therapeutic products, as well as AI-driven solutions that enhance disease detection, treatment, and monitoring. Revenue is generated through the sale of these advanced medical products and solutions, which are integral to improving patient outcomes and healthcare efficiency. Lantheus has a strong focus on innovation, leveraging its extensive experience and expertise to continuously expand its product pipeline and strengthen its diagnostic capabilities. The company’s commitment to better patient outcomes is evident in its collaborative culture and dedication to scientific advancement.
Keywords: diagnostics, therapeutics, AI solutions, healthcare, disease detection, patient outcomes, innovation, medical products, commercialization, diagnostics market.
Tech stack
Investments by Lantheus Holdings
Edit



